Asian Paints:2,575.50-78.01 (-2.94%)
Cipla:1,423.00+13.81 (+0.98%)
Eicher Motors:7,970.00+16.70 (+0.21%)
Nestle India:1,438.20-58.37 (-3.90%)
Grasim Inds:3,305.00-66.07 (-1.96%)
Hindalco Inds.:1,014.40-1.02 (-0.10%)
Hind. Unilever:1,994.80+27.35 (+1.39%)
ITC:266.60+11.09 (+4.34%)
Trent:2,855.00-24.77 (-0.86%)
Larsen & Toubro:3,980.10-64.72 (-1.60%)
M & M:3,259.00-22.97 (-0.70%)
Reliance Industries:1,309.00+32.05 (+2.51%)
Tata Consumer:1,030.50-6.95 (-0.67%)
Tata Motors PVeh:310.00+1.14 (+0.37%)
Tata Steel:184.07-0.28 (-0.15%)
Wipro:181.70-2.80 (-1.52%)
Apollo Hospitals:8,755.00-143.26 (-1.61%)
Dr Reddy's Labs:1,171.00+16.62 (+1.44%)
Titan Company:5,050.00-52.56 (-1.03%)
SBI:1,034.50-25.55 (-2.41%)
Shriram Finance:1,059.10-50.84 (-4.58%)
Bharat Electron:411.20-3.23 (-0.78%)
Kotak Mah. Bank:425.00+5.62 (+1.34%)
Infosys:1,156.00+22.22 (+1.96%)
Bajaj Finance:1,053.90-3.07 (-0.29%)
Adani Enterp.:2,863.90+4.86 (+0.17%)
Sun Pharma.Inds.:1,929.00-55.77 (-2.81%)
JSW Steel:1,313.50+5.75 (+0.44%)
HDFC Bank:711.90+2.91 (+0.41%)
TCS:2,369.00-30.23 (-1.26%)
ICICI Bank:1,438.00-15.99 (-1.10%)
Power Grid Corpn:264.55+1.00 (+0.38%)
Maruti Suzuki:12,950.00-597.44 (-4.41%)
Axis Bank:1,258.00-41.99 (-3.23%)
HCL Technologies:1,351.40+39.23 (+2.99%)
O N G C:236.45+4.66 (+2.01%)
NTPC:327.50+0.10 (+0.03%)
Coal India:401.60-0.16 (-0.04%)
Bharti Airtel:1,877.20+65.23 (+3.60%)
Tech Mahindra:1,638.00+9.93 (+0.61%)
Jio Financial:235.85-5.50 (-2.28%)
Adani Ports:1,647.50+54.33 (+3.41%)
HDFC Life Insur.:540.30-3.04 (-0.56%)
SBI Life Insuran:1,739.30-1.22 (-0.07%)
Max Healthcare:1,003.00-39.08 (-3.75%)
UltraTech Cem.:11,400.00-50.38 (-0.44%)
Bajaj Auto:12,361.00+230.48 (+1.90%)
Bajaj Finserv:1,972.00-48.91 (-2.42%)
Interglobe Aviat:5,052.00-182.15 (-3.48%)
Eternal:327.75-0.36 (-0.11%)
Asian Paints:2,575.50-78.01 (-2.94%)
Cipla:1,423.00+13.81 (+0.98%)
Eicher Motors:7,970.00+16.70 (+0.21%)
Nestle India:1,438.20-58.37 (-3.90%)
Grasim Inds:3,305.00-66.07 (-1.96%)
Hindalco Inds.:1,014.40-1.02 (-0.10%)
Hind. Unilever:1,994.80+27.35 (+1.39%)
ITC:266.60+11.09 (+4.34%)
Trent:2,855.00-24.77 (-0.86%)
Larsen & Toubro:3,980.10-64.72 (-1.60%)
M & M:3,259.00-22.97 (-0.70%)
Reliance Industries:1,309.00+32.05 (+2.51%)
Tata Consumer:1,030.50-6.95 (-0.67%)
Tata Motors PVeh:310.00+1.14 (+0.37%)
Tata Steel:184.07-0.28 (-0.15%)
Wipro:181.70-2.80 (-1.52%)
Apollo Hospitals:8,755.00-143.26 (-1.61%)
Dr Reddy's Labs:1,171.00+16.62 (+1.44%)
Titan Company:5,050.00-52.56 (-1.03%)
SBI:1,034.50-25.55 (-2.41%)
Shriram Finance:1,059.10-50.84 (-4.58%)
Bharat Electron:411.20-3.23 (-0.78%)
Kotak Mah. Bank:425.00+5.62 (+1.34%)
Infosys:1,156.00+22.22 (+1.96%)
Bajaj Finance:1,053.90-3.07 (-0.29%)
Adani Enterp.:2,863.90+4.86 (+0.17%)
Sun Pharma.Inds.:1,929.00-55.77 (-2.81%)
JSW Steel:1,313.50+5.75 (+0.44%)
HDFC Bank:711.90+2.91 (+0.41%)
TCS:2,369.00-30.23 (-1.26%)
ICICI Bank:1,438.00-15.99 (-1.10%)
Power Grid Corpn:264.55+1.00 (+0.38%)
Maruti Suzuki:12,950.00-597.44 (-4.41%)
Axis Bank:1,258.00-41.99 (-3.23%)
HCL Technologies:1,351.40+39.23 (+2.99%)
O N G C:236.45+4.66 (+2.01%)
NTPC:327.50+0.10 (+0.03%)
Coal India:401.60-0.16 (-0.04%)
Bharti Airtel:1,877.20+65.23 (+3.60%)
Tech Mahindra:1,638.00+9.93 (+0.61%)
Jio Financial:235.85-5.50 (-2.28%)
Adani Ports:1,647.50+54.33 (+3.41%)
HDFC Life Insur.:540.30-3.04 (-0.56%)
SBI Life Insuran:1,739.30-1.22 (-0.07%)
Max Healthcare:1,003.00-39.08 (-3.75%)
UltraTech Cem.:11,400.00-50.38 (-0.44%)
Bajaj Auto:12,361.00+230.48 (+1.90%)
Bajaj Finserv:1,972.00-48.91 (-2.42%)
Interglobe Aviat:5,052.00-182.15 (-3.48%)
Eternal:327.75-0.36 (-0.11%)
Arihant Plus App

Arihant Plus App

Gland Pharma Ltd

Gland Pharma | 543245

Market Closed
2,875.00
10.68 (-0.37%)
As on 02/09/26, 6:49 AM
Market Cap47,427.92 CR
Current Price₹2,875
High / Low₹3,039.8 / 1,573.6
PE Ratio27.22
Book Value₹628.67
Dividend Yield1.18%
ROCE14.59%
ROE12.64%
Face Value₹2.00
Current Vol.2,57,559
Average Vol.---
ISININE068V01023
PB Ratio2.7
Debt to Equity0.03
Net Profit Margin15.98
Operating Margin29.88

GLAND - Share Price Chart

+0.00 (+0.00%)6M

Stock Performance

2,885.82,885.7
2,875
Previous CloseToday's Open
1,573.63,039.8
2,875
52W Low52W High
₹2,885.7Today's Open
₹2,885.8Previous Close
2,57,559Volume
₹1,573.652W Low
₹3,039.852W High

Ratios

No data available

About Company

  • Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a Private limited company on March 20, 1978 with the Registrar of Companies, Andhra Pradesh
  • Subsequently, name of the Company was changed to Gland Pharma Limited' and a fresh Certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies at Hyderabad
  • The Company is primarily engaged in manufacturing injectable formulations
  • Established in Hyderabad, India, Company has evolved into a prominent entity in the global generic injectables market, including the United States, Europe, Canada, Australia, and India
  • Primarily functioning, company provides comprehensive services such as contract development, dossier compilation, technology transfer, and manufacturing across various delivery systems
  • Over the years, the company has made substantial investments in the companies manufacturing infrastructure to support the product portfolio needs and reach
  • The company has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 42 production lines and three API facilities
  • The companies API facilities provide with in-house manufacturing capabilities for critical APIs, enabling the company to control costs and quality and mitigate supply chain related risks around the key products
  • The companies capabilities as a vertically integrated company include internal research and development (R&D) expertise, robust manufacturing capabilities, a strict quality assurance system, extensive regulatory experience and established marketing and distribution relationships
  • As of March 31, 2020, the company along with partners had 265 ANDA filings in the United States, of which 204 were approved and 61 were pending approval

Ethics: Gland Pharma Ltd is flagged for

paw image

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

worldwide image

Adequate

The company demonstrates adequate ESG practices with room for improvement.

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI62.82
SMA 202823.81
SMA 502604.55
SMA 1002315.60
SMA 2002027.61
SMA 102853.23
MACD_12_26_Days87.22
EMA10Day2858.76
EMA20Day2800.33
EMA50Day2619.00
MACD_12_26_9_Days-10.76
EMA100Day2400.95
EMA200Day2176.61

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth14.50%
ROE10.53%
EBITDA Margin29.88%

All figures in ₹ Crores

Indicators20262025202420232022
Revenue
6,430.65
5,616.50
5,664.72
3,624.60
4,400.71
Interest
33.28
42.00
26.20
7.45
5.24
Expenses
4,801.11
4,347.58
4,331.65
2,599.84
2,890.56
Financing Profit
1,945.87
1,482.53
1,503.31
1,265.23
1,734.09
Financing Margin %
30%
26%
27%
35%
39%
Other Income
316.33
213.61
170.24
240.46
223.94
Depreciation
423.67
377.87
344.57
146.74
110.30
Profit before tax
1,464.58
1,062.66
1,132.54
1,054.58
1,618.55
Tax %
30%
34%
32%
26%
25%
Net Profit
1,027.32
698.53
772.46
781.04
1,211.66
EPS in Rs
62.35
42.40
46.90
47.44
73.81
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

01 Sept 2026 12:00 am

Volumes jump at Vardhman Textiles Ltd counter

Volumes jump at Vardhman Textiles Ltd counter

Record Date
Corporate Action
Information
Announcement Day
25 Aug 2026
AGM
AGM
15 May 2026
11 Aug 2026
Final Dividend (₹20)
Recommended a final dividend of Rs. 20/- (2000%) per equity share of Rs. 1/- each for the financial year 2025-26.
15 May 2026
28 Aug 2025
AGM
AGM
20 May 2025
14 Aug 2025
Final Dividend (₹18)
Recommended a final dividend of Rs. 18/- (1800%) per equity share of Rs. 1/- each for the financial year 2024-25. The dividend, upon approval by the shareholders, will be paid within 30 days from the date of the 47 th Annual General Meeting (AGM). Pursuant to Regulation 42 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 the record date for the purpose of determining the members eligible to receive the final dividend for the financial year ended March 31, 2025, is Thursday, August 14, 2025
20 May 2025
30 Aug 2024
AGM
AGM
22 May 2024
16 Aug 2024
Final Dividend (₹20)
Recommended a final dividend of Rs. 20/- (2000%) per equity share of Rs. 1/- each for the financial year 2023-24. The dividend, upon approval by the shareholders, will be paid within 30 days from the date of the 46th Annual General Meeting (AGM).
22 May 2024
31 Aug 2023
AGM
AGM
18 May 2023
30 Aug 2022
AGM
AGM
19 May 2022

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
2,868
47,318
41
5
30
0
15.98%
1,930
4,63,180
37
6
30
0
19.78%
9,165
2,43,302
82
15
70
0
24.32%
4,959
1,88,623
85
22
50
1
11.09%
1,164
1,16,114
24
4
18
0
9.82%
1,418
1,14,554
32
3
24
0
9.92%
1,860
1,00,498
92
19
64
1
13.06%
2,150
98,312
17
4
13
0
19.16%
1,171
97,741
30
3
18
0
12.34%
2,360
97,467
46
6
32
0
13.57%
Showing 10 of 140 Results

Frequently Asked Questions

What is Share Price of Gland Pharma Ltd?

The current share price of Gland Pharma Ltd (Gland Pharma) is ₹2875.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Gland Pharma Ltd?

The Price-to-Earnings (P/E) ratio of Gland Pharma Ltd is 2875.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Gland Pharma Ltd?

Gland Pharma Ltd has a 52-week high of ₹3039.80 and a 52-week low of ₹1573.60. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Gland Pharma Ltd?

Gland Pharma Ltd offers a dividend yield of 0.69%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Gland Pharma Ltd?

The Earnings Per Share (EPS) of Gland Pharma Ltd is ₹69.46. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Gland Pharma Ltd?

Gland Pharma Ltd has a Return on Equity (ROE) of 12.64%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2